Publications & Media
On behalf of the CARE™ hematology faculty and our CHC-WEST chair Dr. Carolyn Owen, we are pleased to present CHC-WEST 2020. After reviewing the presentations from CHC national, various faculty...
Au nom du comité académique de CARETM sur l’hématologie et de notre président de la Conférence canadienne sur l’hématologie (CCH-QC), le Dr Dennis Claude Roy, nous sommes heureux de vous présenter...
This year marks the 10th annual Canadian Hematology Conference (CHC), presented virtually for the first time ever! Over the past 10 years, CHC has become the largest multi-disciplinary hematological conference...
Why a Guidance for treating patients during COVID-19 is important: Goal for Gastroenterology Practice in Canada – protect vulnerable patients (specifically those with UC and CD) from potentially fatal infection...
Why Guidance for treating prostate cancer patients during COVID-19 is important Goal – protect vulnerable patients from potentially fatal infection without jeopardizing cancer treatments Cancer Patients generally are at increased...
A multi-disciplinary group of Canadian dermato-oncology KOLs recently participated in virtual CARE™ Working Group Meetings held in June 2020. The aim of these meetings was to review the current state...
Dr. Peter Anglin interviews Dr. Paolo Ghia about treating Chronic Lymphocytic Leukemia during the COVID-19 pandemic. Dr. Paolo Ghia is a professor in Medical Oncology at the Università Vita-Salute San...
Dr. Peter Anglin interviews Dr. María-Victoria Mateos about treating Multiple Myeloma during the COVID-19 pandemic. Dr. María-Victoria Mateos is a consultant physician in the Hematology Department and Associate Professor of...
Why Guidance for treating patients during COVID-19 is important: Goal for Rheumatology Practice in Canada – protect rheumatology patients from potentially fatal infection without jeopardizing treatment goals. Rheumatoid arthritis and...
Why Guidance for treating patients during COVID-19 is important: Goal for Hematology Practice in Canada – protect vulnerable patients from potentially fatal infection, without jeopardizing cancer treatments. Median age of...
